With the rise in usage, providers must be aware of when, how, and why they are able to prescribe or create compounded GLP-1 drugs
If you or a loved one suffered severe health problems after taking GLP-1 receptor agonist drugs such as Ozempic, Wegovy, Mounjaro, Rybelsus, or Trulicity, it is time to find answers fast
T., Waterbury, N
The risks associated with semaglutide may also be present for other GLP-1 agonists, such as tirzepatide (Mounjaro)
The probiotic cultures it claims to contain may be entirely inactive, incorrectly identified, or replaced with unknown substitute organisms, none of which would be detectable by the consumer upon receipt